NFKB1 and Miyoshi myopathy: In particular, several studies identified NF-κB pathway mutations in multiple myeloma (MM) and ABC-DLBCL [9,10,11,12,13,14,15,16,17], as well as in other lymphoma subtypes not covered in this review.